These results are in accordance with previous reports showing that targeting ILK decreases cell viability [22] and induces apoptosis in ovarian cancer [20,21], and increases the sensitivity of lung cancer [26], gastric carcinoma [27], and colon cancer [28] cells to cisplatin or oxaliplatin treatment. Here, ILK is linked to gastric carcinoma.